R. P. Scherer
Executive Summary
Capsule maker completes the acquisition of Polysystems Ltd., a U.K.-based drug delivery R&D firm. Polysystems has an exclusive option on the worldwide rights to Pulsincap, a water-soluble capsule designed to release a drug in the gastrointestinal tract at a given time. R. P. Scherer says the technology "provides an important extension" to the existing rapidly developing drug delivery business of R. P. Scherer, based on the patented Scheresol softgel systems and the Zydis fast-dissolving dosage form.